The past three decades have borne witness to many advances in the understanding of the
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus …

Importance Anti–programmed cell death receptor-1 (PD-1) therapy is standard of care for
incurable recurrent or metastatic non-nasopharyngeal head and neck cancer. In contrast …

Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with high propensity for
lymphatic spread and distant metastasis. It is prominent as an endemic malignancy in …

Head and neck cancer is the 6th most common cancer worldwide with the most common
histology being squamous cell carcinoma (HNSCC). While the majority of patients present at …

Simple Summary Epstein Barr virus (EBV) is often responsible for the onset of both solid and
hematologic malignancies. In particular, it is implicated in the pathogenesis of …

Innovation refers to the introduction of a product, a process, a service or a solution resulting
in something new or significantly improved compared to the already available alternatives …

Introduction: Head and neck squamous cell carcinoma (HNSCC) is one of the most common
cancers worldwide and is a leading cause for cancer-related mortality. This review attempts …

The mutational landscape of NPC has been elucidated by several whole-exome (WES) and
whole-genome (WGS) sequencing studies of NPC published since 2014 (Dai et al. 2020; Li …

The last 5 years have borne witness to a major revival in the use of immunotherapy against
nasopharyngeal cancer (NPC), a milestone that is due largely to the successful …

Squamous cell head and neck cancer (SCHNC) is the seventh most common cancer
worldwide. Most of SCHNC are locally advanced at diagnosis and are treated with …